Key Takeaways & Executive Findings
- •• Stem cell-derived exosomes promote oligodendrocyte repair through immunomodulatory mechanisms. • There is a deep interaction between the exosome functional network and myelin homeostasis. • Engineered exosome delivery systems with targeting peptide modification and functional molecule loading represent a new frontier for precision therapy. • Exosome-based cell-free therapy offers a novel paradigm for treating neurodegenerative and demyelinating diseases by modulating the inflammatory microenvironment.
Abstract
BACKGROUND: The dynamic interplay between the inflammatory microenvironment and oligodendrocytes following neural injury constitutes a central pathological feature in neurodegenerative and demyelinating diseases. Stem cell-derived exosomes, leveraging their inherent low immunogenicity, efficient barrier-penetrating capacity, and targeted delivery of diverse pro-repair factors, play a pivotal role in modulating oligodendrocyte differentiation and the inflammatory microenvironment, thereby facilitating neural repair and regeneration. OBJECTIVE: To investigate the mechanisms by which stem cell-derived exosomes regulate the inflammatory microenvironment to enhance oligodendrocyte survival, differentiation, and myelin repair. It seeks to establish a novel "cell-free therapy" paradigm, utilizing exosome-mediated multi-component synergy (miRNAs, proteins, and metabolites) and microenvironmental adaptation for treating neurological disorders. METHODS: Literature searches were conducted in the China National Knowledge Infrastructure, PubMed, and WanFang databases, covering publications from 2010 to 2025. Chinese search terms included "exosomes, stem cells, engineered, diagnosis, inflammatory microenvironment, oligodendrocytes, signaling pathways," while English terms comprised "stem cell-derived exosomes, oligodendrocytes, inflammatory microenvironment, signaling pathway, regulatory mechanisms." Irrelevant studies were excluded, and 65 articles meeting inclusion criteria were systematically reviewed according to the inclusion and exclusion criteria. RESULTS AND CONCLUSION: (1) The biological characteristics of exosomes and their roles in the central nervous system were summarized, analyzing the impact of the inflammatory microenvironment on oligodendrocytes and the regulatory mechanisms of exosomes, including miRNA-mediated signaling pathway regulation, anti-inflammatory factor secretion, and immune cell function modulation. (2) The regulatory mechanisms of the inflammatory microenvironment on oligodendrocyte biological behavior and their roles in disease pathogenesis were elaborated. (3) An engineered exosome delivery system based on targeting peptide modification and functional molecule loading, combined with traditional Chinese medicine active ingredient regulation strategies, was proposed to construct a novel cell-free therapy paradigm. (4) The deep interaction between the exosome functional network and myelin homeostasis was explained at the molecular level, providing new therapeutic directions for the development of exosome-targeted delivery systems to intervene in central nervous system demyelinating diseases.
1. Introduction
In recent years, stem cell-derived exosomes have become a research hotspot in the field of neural repair due to their unique biological properties, especially the mechanism by which they enhance the regenerative capacity of oligodendrocytes by modulating the inflammatory microenvironment. The inflammatory microenvironment is a common feature of various neurological diseases, composed of microglia, astrocytes, infiltrating immune cells, and inflammatory factors [1-2]. Traditional anti-inflammatory treatments (such as glucocorticoids) have issues of significant side effects and poor targeting. In contrast, stem cell-derived exosomes, as important mediators of intercellular communication, not only retain the therapeutic properties of parent cells but also possess advantages such as low immunogenicity, high stability, and good tissue tropism, playing a key role in neuroinflammation and myelin repair.
Studies have shown that stem cell-derived exosomes can deliver bioactive molecules such as miRNAs, proteins, and lipids to regulate microglia/macrophage polarization, inhibit the release of pro-inflammatory factors, promote oligodendrocyte precursor cell differentiation and myelin repair, providing new therapeutic strategies for central nervous system injury repair [3-5]. This article explores how stem cell-derived exosomes regulate the inflammatory microenvironment to promote oligodendrocyte survival, differentiation, and myelin repair, as well as the mechanisms by which they enhance the regenerative capacity of oligodendrocytes, providing a novel "cell-free therapy" paradigm for treating neurological diseases through multi-component synergy (miRNA, protein, metabolites) and microenvironmental adaptation (inflammation suppression, vascular support).
Loading authentic research manuscript (Pages 1–5)...
ZHANG Xixian (2026). Stem cell-derived exosomes modulate the inflammatory microenvironment and enhance regenerative capacity of oligodendrocytes. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21354
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What are stem cell-derived exosomes?
Stem cell-derived exosomes are extracellular vesicles (30-150 nm in diameter) secreted by stem cells. They contain bioactive components such as nucleic acids, proteins, and lipids, and participate in intercellular communication, immune regulation, and tissue repair.
How do stem cell-derived exosomes modulate the inflammatory microenvironment?
They deliver miRNAs, proteins, and lipids to regulate microglia/macrophage polarization, inhibit pro-inflammatory factor release, and promote anti-inflammatory responses, thereby creating a favorable microenvironment for oligodendrocyte repair.
What is the role of oligodendrocytes in the central nervous system?
Oligodendrocytes wrap around axons to form insulating myelin sheaths, facilitating rapid saltatory conduction of electrical signals and maintaining neuronal function. Their dysfunction leads to demyelinating diseases.
What is the significance of engineered exosomes in this context?
Engineered exosomes, modified with targeting peptides and loaded with functional molecules, enhance specificity and therapeutic efficacy, representing a new frontier for precision therapy in neurological diseases.
What are the future challenges for clinical translation of exosome-based therapies?
Challenges include addressing exosome heterogeneity, deeply understanding the mechanisms of exosome-mediated oligodendrocyte repair, and overcoming multiple hurdles in clinical translation such as large-scale production and quality control.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.